Nomifensine Maleate in Adult Attention Deficit Disorder

@article{Shekim1989NomifensineMI,
  title={Nomifensine Maleate in Adult Attention Deficit Disorder},
  author={Walid O. Shekim and Alex Masterson and Dennis P. Cantwell and James T. McCracken},
  journal={The Journal of Nervous and Mental Disease},
  year={1989},
  volume={177},
  pages={296–299}
}
The authors studied 18 adults (8 men and 10 women) in an open trial of nomifensine maleate for the treatment of attention deficit disorder (ADD). All patients met DSM-III criteria and the Utah criteria for ADD, residual type (RT). Medication effect was measured at week 1 and week 4 of treatment using the Structured Interview for ADD-H Symptoms. Data from week 4 showed that all eight men and seven of the women responded well to nomifensine, showing a significant decrease in ADD with… 
A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder
TLDR
Under controlled conditions, the aggregate literature shows that the stimulants and noradrenergic antidepressants had a clinically and statistically significant beneficial effect on treating ADHD in adults.
Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults
TLDR
The majority of studies suggest that stimulants are the most effective available agents for adults with ADHD, and these drugs remain the treatment of choice.
A One Year Trial of Methylphenidate in the Treatment of ADHD
Objective: To determine the effects of long-term methylphenidate treatment on symptom severity and social adjustment in adult ADHD. Method: Adults (n = 116) meeting operational diagnostic criteria
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
TLDR
The aggregate literature shows that the stimulants and catecholaminergic nonstimulants investigated had a clinically significant beneficial effect on treating ADHD in adults.
Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder
TLDR
Under controlled conditions, the aggregate literature, comprised mainly of short-term studies, shows that stimulants, norepinephrine reuptake inhibitors and specific antidepressants had clinically and statistically significant beneficial effects in the treatment of ADHD in adults.
Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review.
TLDR
The literature appears to support the use of robust doses of both stimulants and antidepressants for ADHD in adults, and controlled studies applying stringent diagnostic criteria and outcome methodology are necessary to define the range of pharmacotherapeutic options.
Alternative pharmacological strategies for adult ADHD treatment: a systematic review
TLDR
Among alternative compounds, amphetamines have the most robust evidence of efficacy, but they may be associated with serious side effects (e.g. psychotic symptoms or hypertension), and antidepressants, particularly those acting as noradrenaline or dopamine enhancers, have evidence of effective but should be avoided in patients with comorbid bipolar disorder.
Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.
TLDR
Psychometric data support continued use of the WRAADDS in adults with ADHD and changes in response to treatment for the W RAADDS and CAARS were highly correlated.
Attention-Deficit Hyperactivity Disorder
TLDR
Therapeutic approaches to ADHD should be multimodal, including medications, family, and educational therapies, and useful drug therapies that are known to affect dopamine and norepinephrine metabolism are discussed.
...
1
2
3
...